Athira Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Athira Pharma and buy or sell other stocks, ETFs, and their options commission-free!About ATHA
LeonaBio, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018.
CEOMark J. Litton, PhD, MBA
CEOMark J. Litton, PhD, MBA
Employees26
Employees26
HeadquartersBothell, Washington
HeadquartersBothell, Washington
Founded2011
Founded2011
Employees26
Employees26
ATHA Key Statistics
Market cap14.28M
Market cap14.28M
Price-Earnings ratio-0.68
Price-Earnings ratio-0.68
Dividend yield—
Dividend yield—
Average volume118.43K
Average volume118.43K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$8.36
52 Week high$8.36
52 Week low$2.20
52 Week low$2.20
Stock Snapshot
As of today, Athira Pharma(ATHA) shares are valued at $3.62. The company's market cap stands at 14.28M, with a P/E ratio of -0.68.
On 2026-01-14, Athira Pharma(ATHA) stock opened at —, reached a high of —, and a low of —.
Athira Pharma(ATHA) shares are trading with a volume of 0, against a daily average of 118.43K.
In the last year, Athira Pharma(ATHA) shares hit a 52-week high of $8.36 and a 52-week low of $2.20.
In the last year, Athira Pharma(ATHA) shares hit a 52-week high of $8.36 and a 52-week low of $2.20.
People also own
Based on the portfolios of people who own ATHA. This list is generated using Robinhood data, and it’s not a recommendation.